UNSPSC 85819304: Transfusion of autologous factor ix into peripheral vein, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to transfusion of autologous factor ix into peripheral vein, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 30233W0

UNSPSC 85819304 Transfusion of autologous factor IX into peripheral vein, percutaneous approach is a Commodity code, but the recent state and local opportunities posted under it show little relevance to the code's clinical scope. The sourced solicitations—spanning disability medical evaluation services, surgical benefit carve-outs, occupational medical surveillance, emergency and inpatient healthcare for detained youth, pharmacy benefit management, and temporary health professional staffing—describe administrative healthcare procurement, medical services contracting, and benefits program management rather than a specific transfusion procedure or related hematologic therapeutics. The mismatch between the code's clinical specificity and the broad healthcare services being solicited suggests either systematic tagging error in the originating procurement system or that the code is not the appropriate classification vehicle for the work actually posted. State and local governments do purchase healthcare services, but these particular opportunities do not align with autologous factor IX transfusion procurement or similar specialty infusion therapy.

Geographic activity spans multiple states: Arizona (City of Phoenix), California (City of Long Beach and County of Santa Clara), Washington (Washington State Department of Transportation), Texas (Harris County), and Florida (Collier County). Issuing bodies include municipal procurement offices, county boards of commissioners, state transportation departments, county health systems, and juvenile justice authorities. Representative recent opportunities include the Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the City of Long Beach's RFP for surgical benefit carve-out management (HR26753, due October 7, 2026), and the Washington State Department of Transportation's RFP for occupational medical surveillance services (RFP20260825, due October 9, 2026). No recent procurement activity under this code directly addresses transfusion procedures, infusion therapy contracting, or related factor replacement services.